Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.08

-2.9%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (8631)	6/5/2003 5:54:23 PM
From: Ian@SI	Read Replies (2) of 52153

Clearly there is some froth in the air - not quite sure how much froth makes a full-fledged bubble, though. <g> Isn't part of this a McLellan<sp?> "dividend"? I believe the market is discarding part of the FDA risk premium. I don't think that IMCLE would have responded the way it has to the Erbitux BLA announcement if Velcade hadn't been approved so rapidly by McLellan's FDA. Now up almost $14!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next